Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jan
18
2022
Federal Marijuana Reform: You Can’t Always Get What You Want? Bradley Arant Boult Cummings LLP
Jan
18
2022
Co-Owner of Clinical Trial Company Pleads Guilty to Obstruction of Justice in Connection with Falsification of Clinical Trial Data Mintz
Jan
18
2022
Supreme Court Halts Implementation of OSHA Vaccine-or-Test Rule (US) Squire Patton Boggs (US) LLP
Jan
18
2022
OSHA’s “Vax-or-Test” ETS: Where Do We Go From Here? (US) Squire Patton Boggs (US) LLP
Jan
18
2022
Not Positive: Last Week’s Lab Fraud Schemes Tycko & Zavareei LLP
Jan
18
2022
Tennessee Lawmakers to Consider Multiple Cannabis Proposals Bradley Arant Boult Cummings LLP
Jan
18
2022
Egg Regulatory Program Standards Announced Keller and Heckman LLP
Jan
15
2022
After the Supreme Court Decision, What Comes Next for OSHA and COVID-19 Beveridge & Diamond PC
Jan
15
2022
Minneapolis and St. Paul to Require Proof of Vaccination or Negative Test for Certain Businesses Jackson Lewis P.C.
Jan
15
2022
Building on the Success of Medicare-Medicaid Plans, CMS Proposes Modifications for D-SNPs Mintz
Jan
15
2022
Greenberg Traurig January 2022 Competition Currents: China and Japan Greenberg Traurig, LLP
Jan
14
2022
New York City Passes the Sweet Truth Act Keller and Heckman LLP
Jan
14
2022
Italian Ministers Announce Timetable for Investment in Digital Health Squire Patton Boggs (US) LLP
Jan
14
2022
EPA Accepting Comments on Candidates to Be Ad Hoc Reviewers for Draft TSCA Systematic Review Protocol Bergeson & Campbell, P.C.
Jan
14
2022
Amniotic Fluid Injections Are at the Center of the Federal Government’s New Enforcement Effort Oberheiden P.C.
Jan
14
2022
SCOTUS Narrowly Allows CMS Vaccine Mandate to Survive; Preemption Battles to Ensue Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
13
2022
Mississippi Senate Overwhelmingly Approves Medical Cannabis Act, Sending Act to House Bradley Arant Boult Cummings LLP
Jan
13
2022
CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now Epstein Becker & Green, P.C.
Jan
13
2022
FDA Revokes Standard for French Dressing Keller and Heckman LLP
Jan
13
2022
Day Three Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022 Sheppard, Mullin, Richter & Hampton LLP
Jan
13
2022
McDermott 2022 Health Policy Outlook McDermott Will & Schulte LLP
Jan
13
2022
Going, Going, Gone? Regulatory Nexus in TSCA Risk Evaluations of Existing Chemicals Keller and Heckman LLP
Jan
13
2022
US Supreme Court Halts Federal Vaccination Mandate for Employers, but Permits CMS Rule to Take Effect Varnum LLP
Jan
12
2022
Planting the Seeds: The Present State and Potential Prospects of Medical Cannabis in Tennessee Bradley Arant Boult Cummings LLP
Jan
12
2022
CMS Proposes Rule to Lower Part D Drug Costs for Beneficiaries K&L Gates LLP
Jan
12
2022
FDA Releases Guidances on Transition Plan for Devices Distributed Under Emergency Use Authorization (EUA) or Enforcement Policies During COVID-19 Sheppard, Mullin, Richter & Hampton LLP
Jan
12
2022
Taking Stock of the Alabama Medical Cannabis Sweepstakes: Still Time to Enter Bradley Arant Boult Cummings LLP
Jan
12
2022
FDA Updates Procedures for Retail Food Safety Personnel Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters